FDA Approves Cefepime-Zidebactam Injection - Quiz - MDSpire

FDA Approves Cefepime-Zidebactam Injection

Phase 3 ENHANCE-1 results showed higher composite clinical cure and microbiologic response rates with cefepime-zidebactam vs meropenem in hospitalized adults with complicated urinary tract infection or acute pyelonephritis.

  • By

  • Kathryn Wighton

  • June 3, 2026

  • 2 min

Share

Original Source(s)

FDA Approves Cefepime-Zidebactam Injection

  • by Kathryn Wighton

  • June 3, 2026

Related Content

Gut microbiota and sepsis-associated acute kidney injury: a narrative review

Severe cutaneous anthrax with systemic complications: a case report

Computational discovery of PGD, MAPK14, and KRAS as diagnostic biomarkers for neonatal sepsis through integrated machine learning, immune infiltration analysis, and molecular docking